49 y/o AA male presents with relapsed multiple myeloma after receiving daratumumab monotherapy

Clinical Case Snapshots published on January 25, 2017
Download Patient Chart
Which of the following triplet drug regimens would you choose to treat this patient?

Submit


Last modified: January 5, 2017